TY - JOUR
T1 - A role for the autophagic receptor, SQSTM1/p62, in trafficking NF-κB/RelA to nucleolar aggresomes
AU - Lobb, Ian T.
AU - Morin, Pierre
AU - Martin, Kirsty
AU - Thoms, Hazel C.
AU - Wills, Jimi C.
AU - Lleshi, Xhordi
AU - Olsen, Karl C. F.
AU - Duncan, Rory R.
AU - Stark, Lesley A.
N1 - Funding Information:
We would like to thank Terje Johansen (UIT, Artic University of Norway) for kindly providing the GFP-p62 plasmid. Simon Wilkinson (ECRC, University of Edinburgh) for providing tools, reagents, and advice, and Alison Dunn for expertise and help with FCS. C. Nicol provided help with figure preparation. The work was funded by WWCR (formally AICR; 10-0158 to L.A. Stark), Rosetrees Trust (A631, JS16/M225 to L.A. Stark), MRC (MR/J001481/1 MR/K01563X/1 to R.R. Duncan), University of Edinburgh scholarships (to I.T. Lobb), and BBSRC (BB/S018530/1).
Funding Information:
P. Morin reports grants from Medical Research Council during the conduct of the study. R.R. Duncan reports grants from Medical Research Council during the conduct of the study. L.A. Stark reports grants from Medical Research Council during the conduct of the study. No disclosures were reported by the other authors.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2021/2
Y1 - 2021/2
N2 - Elevated NF-kB activity is a contributory factor in many hematologic and solid malignancies. Nucleolar sequestration of NF-kB/ RelA represses this elevated activity and mediates apoptosis of cancer cells. Here, we set out to understand the mechanisms that control the nuclear/nucleolar distribution of RelA and other regulatory proteins, so that agents can be developed that specifically target these proteins to the organelle. We demonstrate that RelA accumulates in intranucleolar aggresomes in response to specific stresses. We also demonstrate that the autophagy receptor, SQSTM1/p62, accumulates alongside RelA in these nucleolar aggresomes. This accumulation is not a consequence of inhibited autophagy. Indeed, our data suggest nucleolar and autophagosomal accumulation of p62 are in active competition. We identify a conserved motif at the N-terminus of p62 that is essential for nucleoplasmic-to-nucleolar transport of the protein. Furthermore, using a dominant-negative mutant deleted for this nucleolar localization signal (NoLS), we demonstrate a role for p62 in trafficking RelA and other aggresome-related proteins to nucleoli, to induce apoptosis. Together, these data identify a novel role for p62 in trafficking nuclear proteins to nucleolar aggresomes under conditions of cell stress, thus maintaining cellular homeostasis. They also provide invaluable information on the mechanisms that regulate the nuclear/nucleolar distribution of RelA that could be exploited for therapeutic purpose. Implications: The data open up avenues for the development of a unique class of therapeutic agents that act by targeting RelA and other aberrantly active proteins to nucleoli, thus killing cancer cells.
AB - Elevated NF-kB activity is a contributory factor in many hematologic and solid malignancies. Nucleolar sequestration of NF-kB/ RelA represses this elevated activity and mediates apoptosis of cancer cells. Here, we set out to understand the mechanisms that control the nuclear/nucleolar distribution of RelA and other regulatory proteins, so that agents can be developed that specifically target these proteins to the organelle. We demonstrate that RelA accumulates in intranucleolar aggresomes in response to specific stresses. We also demonstrate that the autophagy receptor, SQSTM1/p62, accumulates alongside RelA in these nucleolar aggresomes. This accumulation is not a consequence of inhibited autophagy. Indeed, our data suggest nucleolar and autophagosomal accumulation of p62 are in active competition. We identify a conserved motif at the N-terminus of p62 that is essential for nucleoplasmic-to-nucleolar transport of the protein. Furthermore, using a dominant-negative mutant deleted for this nucleolar localization signal (NoLS), we demonstrate a role for p62 in trafficking RelA and other aggresome-related proteins to nucleoli, to induce apoptosis. Together, these data identify a novel role for p62 in trafficking nuclear proteins to nucleolar aggresomes under conditions of cell stress, thus maintaining cellular homeostasis. They also provide invaluable information on the mechanisms that regulate the nuclear/nucleolar distribution of RelA that could be exploited for therapeutic purpose. Implications: The data open up avenues for the development of a unique class of therapeutic agents that act by targeting RelA and other aberrantly active proteins to nucleoli, thus killing cancer cells.
UR - http://www.scopus.com/inward/record.url?scp=85100379114&partnerID=8YFLogxK
U2 - 10.1158/1541-7786.MCR-20-0336
DO - 10.1158/1541-7786.MCR-20-0336
M3 - Article
C2 - 33097627
SN - 1541-7786
VL - 19
SP - 274
EP - 287
JO - Molecular Cancer Research
JF - Molecular Cancer Research
IS - 2
ER -